Naveen Pemmaraju congratulates new interns, reflecting back on his first year

Naveen Pemmaraju shared on X:

“Wishing all a Happy July 1st! Shout outs go to all of the brand new interns starting their medical training journey!

I still fondly remember my own intern year for The Osler Medical Residency, July 1st, 2005 at Johns Hopkins Medicine.”

Source: Naveen Pemmaraju/X

Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network. He is also the Leukemia Hematology/Oncology Course Director.

His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML.